disease of newborn
Conditions
Interventions
A:sevoflurane inhalation
B:sevoflurane and fentanyl iv
C:sevoflurane and caudal 0.2% levobupivacaine
D:sevoflurane and 1mg/kg ketamine iv
E:sevoflurane and caudal 0.2% levobupivacaine and 1ug/kg fentanyl
F:sevoflurane and caudal 0.2% levobupivacaine and 0.5mg/kg ketamine
Sponsors
Guangzhou Women and Childrens Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: full-term neonates, weight: 2.5-4.5kg, ASA grade: I, II
Exclusion criteria
Exclusion criteria: neonates were excluded if they have cardiorespiratory, renal or hepatic dysfunction. Neonates were excluded if they receive medications known to affect anesthetic requirements or allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MACV-BAR; | — |
Secondary
| Measure | Time frame |
|---|---|
| duration of postoperative analgesia; | — |
Contacts
Public ContactSong Xingrong
Outcome results
None listed